{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T16:57:17Z","timestamp":1720025837270},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.cca.2013.08.003","type":"journal-article","created":{"date-parts":[[2013,8,14]],"date-time":"2013-08-14T04:03:45Z","timestamp":1376453025000},"page":"259-264","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Utility of cystatin C as a marker for the severity of aortic regurgitation in hypertensive patients"],"prefix":"10.1016","volume":"425","author":[{"given":"Masato","family":"Iida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko S.","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruo","family":"Honjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaichirou","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2013.08.003_bb0005","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0735-1097(00)00744-0","article-title":"Prevalence and correlates of aortic regurgitation in American Indians: the Strong Heart Study","volume":"36","author":"Lebowitz","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2013.08.003_bb0010","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0002-9149(98)01064-9","article-title":"Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)","volume":"83","author":"Singh","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cca.2013.08.003_bb0015","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/01.hjh.0000163157.14493.c7","article-title":"Aortic valve sclerosis is associated with preclinical cardiovascular disease in hypertensive adults: the Hypertension Genetic Epidemiology Network study","volume":"23","author":"Agno","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.cca.2013.08.003_bb0020","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.amjmed.2010.06.018","article-title":"Pulmonary hypertension and long-term mortality in aortic and mitral regurgitation","volume":"123","author":"Parker","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.cca.2013.08.003_bb0025","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/eurheartj\/ehi248","article-title":"Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors","volume":"26","author":"Fondard","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cca.2013.08.003_bb0030","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1096\/fj.06-7924com","article-title":"Cathepsin cysteine proteases in cardiovascular disease","volume":"21","author":"Lutgens","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.cca.2013.08.003_bb0035","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1161\/01.ATV.0000228824.01604.63","article-title":"Increased expression of elastolytic cathepsins S, K, and V and their inhibitor cystatin C in stenotic aortic valves","volume":"26","author":"Helske","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2013.08.003_bb0040","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1373\/clinchem.2009.128397","article-title":"Cystatin C and cardiovascular risk","volume":"55","author":"Taglieri","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2013.08.003_bb0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCHEARTFAILURE.108.807271","article-title":"Association of cystatin C with left ventricular structure and function: the Dallas Heart Study","volume":"2","author":"Patel","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cca.2013.08.003_bb0050","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cardfail.2006.07.005","article-title":"Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study","volume":"12","author":"Ix","year":"2006","journal-title":"J Card Fail"},{"key":"10.1016\/j.cca.2013.08.003_bb0055","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jacc.2006.10.061","article-title":"Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study","volume":"49","author":"Maurer","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2013.08.003_bb0060","doi-asserted-by":"crossref","first-page":"497","DOI":"10.7326\/0003-4819-142-7-200504050-00008","article-title":"Cystatin C concentration as a risk factor for heart failure in older adults","volume":"142","author":"Sarnak","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cca.2013.08.003_bb0065","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/cvr\/cvq138","article-title":"Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulation","volume":"87","author":"Xie","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cca.2013.08.003_bb0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/01.HYP.28.1.47","article-title":"Effect of hypertension on aortic root size and prevalence of aortic regurgitation","volume":"28","author":"Kim","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2013.08.003_bb0075","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM199907153410302","article-title":"Association of aortic\u2013valve sclerosis with cardiovascular mortality and morbidity in the elderly","volume":"341","author":"Otto","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2013.08.003_bb0080","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0735-1097(97)00344-6","article-title":"Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures","volume":"30","author":"Nagueh","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2013.08.003_bb0085","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.CIR.102.5.558","article-title":"Assessment of severity of aortic regurgitation using the width of the vena contracta: a clinical color Doppler imaging study","volume":"102","author":"Tribouilloy","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2013.08.003_bb0090","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0894-7317(03)00335-3","article-title":"Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography","volume":"16","author":"Zoghbi","year":"2003","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cca.2013.08.003_bb0095","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cca.2013.08.003_bb0100","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/ndt\/gfl249","article-title":"Does the ID-MS traceable MDRD equation work and is it suitable for use with compensated Jaffe and enzymatic creatinine assays?","volume":"21","author":"Vickery","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cca.2013.08.003_bb0105","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cca.2013.08.003_bb0110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jash.2009.01.002","article-title":"Cystatin C is associated with the metabolic syndrome and other cardiovascular risk factors in a hypertensive population","volume":"3","author":"Vigil","year":"2009","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.cca.2013.08.003_bb0115","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/0192623307312707","article-title":"Cardiac valvular pathology: comparative pathology and animal models of acquired cardiac valvular diseases","volume":"36","author":"Donnelly","year":"2008","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.cca.2013.08.003_bb0120","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0735-1097(01)01484-X","article-title":"C-reactive protein is increased in patients with degenerative aortic valvular stenosis","volume":"38","author":"Galante","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2013.08.003_bb0125","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2008.04.011","article-title":"C-reactive protein predicts severity, progression, and prognosis of asymptomatic aortic valve stenosis","volume":"156","author":"Imai","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.cca.2013.08.003_bb0130","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.jacc.2007.07.064","article-title":"Clinical factors, but not C-reactive protein, predict progression of calcific aortic\u2013valve disease: the Cardiovascular Health Study","volume":"50","author":"Novaro","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2013.08.003_bb0135","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.atherosclerosis.2004.01.028","article-title":"Inflammation, infection, and aortic valve sclerosis; Insights from the Olmsted County (Minnesota) population","volume":"174","author":"Agmon","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2013.08.003_bb0140","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijcard.2010.02.035","article-title":"Increased serum neopterin in patients with nonrheumatic aortic valve stenosis","volume":"145","author":"Naito","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cca.2013.08.003_bb0145","doi-asserted-by":"crossref","first-page":"H756","DOI":"10.1152\/ajpheart.00900.2008","article-title":"Elevated cyclic stretch alters matrix remodeling in aortic valve cusps: implications for degenerative aortic valve disease","volume":"296","author":"Balachandran","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cca.2013.08.003_bb0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.atherosclerosis.2007.09.022","article-title":"Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate","volume":"198","author":"Niccoli","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2013.08.003_bb0155","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.atherosclerosis.2007.11.025","article-title":"Cystatin C\u2014a marker of peripheral atherosclerotic disease?","volume":"199","author":"Arpegard","year":"2008","journal-title":"Atherosclerosis"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113003021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113003021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T00:28:20Z","timestamp":1539476900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898113003021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":31,"alternative-id":["S0009898113003021"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2013.08.003","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of cystatin C as a marker for the severity of aortic regurgitation in hypertensive patients","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2013.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}